IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Senores Pharmaceuticals IPO listing price is ₹ 609.00, issue price is ₹ 391.00, and currently trading at ₹ 584.15 as on July 1, 2025. Senores Pharmaceuticals IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Senores Pharmaceuticals IPO is a Book building listing on BSE,NSE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Ambit , Equirus Capital , Nuvama Wealth Management are the merchant bankers of Senores Pharmaceuticals IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 26th July 2024.
Senores Pharmaceuticals IPO offer price is ₹ 391.00 and got listed at ₹ 609.00. Read Senores Pharmaceuticals IPO details mentioned above.The IPO of Senores Pharmaceuticals Limited was listed on 30th December 2024. As of today, Senores Pharmaceuticals IPO is trading at ₹ 584.15, compared to the previous day’s close of ₹ 582.65. Read the report above for detailed IPO performance.
The issue price of Senores Pharmaceuticals IPO was ₹ 391.00 per equity share.
Senores Pharmaceuticals IPO was listed at ₹609.00 on the stock exchange on 30th December 2024. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of July 1, 2025, the current market price of Senores Pharmaceuticals IPO is ₹ 584.15.
The 52-week high for Senores Pharmaceuticals IPO is ₹ 665.00, while the 52-week low is ₹ 435.25. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Senores Pharmaceuticals IPO listed at ₹ 609.00 against the issue price of ₹ 391.00 per equity share, showing a listing day gain/loss of 218 (55.75%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Senores Pharmaceuticals IPO stock moved from its listing price of ₹ 609.00 to the current price of ₹584.15 per equity share, reflecting a change of -4.08% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Senores Pharmaceuticals IPO issue date of 30th December 2024 and CMP of ₹584.15, the estimated CAGR is approximately 122.71%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 391.00
Listing Price :
₹ 609.00
Previous Day Closing
₹ 582.65
Senores Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Senores Pharmaceuticals Financial Review Page
Merchant Banker(s) of Senores Pharmaceuticals IPO: Ambit Private Limited , Equirus Capital Private Limited , Nuvama Wealth Management Limited
Senores Pharmaceuticals IPO subscription was 97.86 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Senores Pharmaceuticals IPO listed at a listing price of 609.00 against the offer price of 391.00.
The current market price of Senores Pharmaceuticals is 584.15.
Why Us?
